Sniffing out the best allergy treatment

November 28, 2017 by Serena Gordon, Healthday Reporter

(HealthDay)—Seasonal allergies make life miserable for millions of Americans.

So, in a bid to ease some of that discomfort, experts from two leading groups of allergists created a that has just issued new practice guidelines on the best ways to quell those bothersome symptoms.

The consensus? For most people, nasal steroid sprays are the way to go, according to the American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI).

The sprays are easy to get—many are available over-the-counter. And, they're relatively inexpensive. For the OTC versions, a month of treatment is about $15 to $20. OTC brand names include Nasacort, Nasonex, Flonase and Rhinocort, while prescription brands include Beconase, Qnasl and Veramyst, according to the AAAAI.

But the biggest reason the experts are recommending is that they're generally more effective than other types of medicine for the initial treatment of seasonal allergies, according to the new guidelines.

Plus, they have relatively few side effects, according to Dr. Punita Ponda, associate chief of allergy and immunology at Northwell Health in Great Neck, N.Y.

Nasal sprays aren't perfect, however. "They can cause itching of the nose, dryness of the nose and nosebleeds," Ponda said. But, she added, using the proper technique can help lessen these side effects. She suggested asking your doctor to show you how to use these devices.

Seasonal allergies are often called hay fever and they span the seasons. The Nemours Foundation reports that people can be allergic to one or more types of pollen or mold, and the type dictates when symptoms strike.

For example, in the Middle Atlantic states, tree pollen is the culprit from February through May, followed by grass pollens from May through June, and weed pollens from August through October. Mold spores, meanwhile, typically peak from midsummer through the fall, depending on where you live, according to the foundation.

The new guidelines recommend nasal steroid sprays as the initial treatment for people aged 12 and older instead of an oral antihistamine such as Benadryl, Zyrtec, Claritin and Allegra. The task force didn't find evidence of an improvement in results if oral antihistamines were added to treatment, and these drugs may cause sleepiness.

In people 15 and over, the task force recommends starting treatment with a nasal steroid spray instead of a leukotriene receptor antagonist (such as Singulair or Accolate). Again, the nasal spray appears to be more effective. Singulair and Accolate are prescription drugs, so cost depends on your insurance plan.

For people with moderate to severe who are older than 12, the task force suggests adding an intranasal antihistamine to treatment with a nasal steroid inhaler. The additional medication provided additional benefit for those with more severe allergies, the task force said.

Ponda noted that the task force didn't recommend intranasal steroids for kids under 12.

"It may be easier to give oral antihistamines than intranasal steroids to children, and there's concern about possible growth suppression. Oral antihistamines were thought to be useful for this group," she said.

Dr. Luz Fonacier, who directs the allergy training program at NYU Winthrop Hospital in Mineola, N.Y., also pointed out that the medications in "this guideline for initial treatment of mild seasonal [allergies] may be obtained OTC, and therefore may have been tried by the patient."

She said that for people who aren't helped by , oral antihistamines, nasal antihistamines and leukotriene receptor antagonists may lessen symptoms.

Ponda said if nasal steroids and additional drugs don't control allergy symptoms well, or if someone just gets tired of having to use medications regularly, are also an option.

"Allergy shots have been shown to be cost-effective compared to medications. Usually, you get one shot a week for six months, and then once a month for three to five years. It's definitely a commitment, but it's the only that's actually disease-modifying. Allergy shots actually make a person less allergic or non-allergic," Ponda explained.

The new guidelines were published online Nov. 27 in the Annals of Internal Medicine.

Explore further: Two meds not always better than one for seasonal allergic rhinitis

More information: Punita Ponda, M.D., associate chief, allergy and immunology, Northwell Health, Great Neck, N.Y.; Luz Fonacier, M.D., allergy training program director, NYU Winthrop Hospital, Mineola, N.Y.; Nov. 27, 2017, Annals of Internal Medicine.

Learn more about seasonal allergies from the American Academy of Allergy, Asthma and Immunology.

Related Stories

Two meds not always better than one for seasonal allergic rhinitis

November 7, 2017
In a newly updated clinical practice guideline, published in Annals of Allergy, Asthma and Immunology, allergists offer practical advice on the best types and amounts of medications to treat seasonal allergic rhinitis. Annals ...

Don't let fall allergies leave you in the cold

November 17, 2017
As the cooler weather moves in, the potential for fall allergies increases. One University of Alabama at Birmingham ear, nose and throat specialist says taking the right precautions and being aware of the causes can significantly ...

Spring is here, but so are allergies

March 21, 2014
Spring has finally arrived in Cincinnati, but soon to follow will be the coughing, sneezing and wheezing that comes with allergies, hay fever and asthma—three warm weather killjoys most could do without.

Ready for spring allergies?

March 30, 2017
(HealthDay)—Spring routinely spells misery for allergy sufferers, but a recent survey reveals that most patients don't try to manage their symptoms until it's too late.

BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis

July 10, 2017
The Standards of Care Committee of the British Society for Allergy & Clinical Immunology (BSACI) is to publish updated guidance on the diagnosis and management of allergic and non-allergic rhinitis. Allergic rhinitis is common ...

Easing your child's allergies

June 16, 2016
(HealthDay)—Up to 40 percent of children in the United States have nasal allergies, the U.S. Food and Drug Administration says.

Recommended for you

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

New immunotherapy targeting blood-clotting protein

October 15, 2018
Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier—which keeps large molecules in the blood from entering the brain—becomes abnormally permeable, ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Immune health maintained by meticulously ordered DNA

October 15, 2018
Walter and Eliza Hall Institute researchers have revealed how immune health is maintained by the exquisite organisation skills of a protein called Pax5.

Enzyme that triggers autoimmune responses from T-cells in patients with MS found

October 11, 2018
A team of researchers from Switzerland, the U.S. and Spain has isolated an enzyme that triggers an autoimmune response from T-cells in patients with MS. In their paper published in the journal Science Translational Medicine, ...

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.